GlassScriptPhysician profile
Gregory S Tamagnini
NPI 1700122660
$11,680.35
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,383 · 2020: $822 · 2021: $780 · 2022: $2,668 · 2023: $1,706 · 2024: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,088 · Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,088.41 |
| Food and Beverage | $938.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $4,901.33 | 2019-2020 | |
| Kerecis Limited | $1,898.53 | 2019-2022 | |
| Paragon 28, INC. | $1,437.58 | 2021-2023 | Monkey Rings, Portfolio, Grappler |
| Smith+Nephew, INC. | $843.65 | 2020-2023 | Grafix, Grafix Pl |
| Integra Lifesciences Corporation | $742.61 | 2019-2022 | |
| Stryker Corporation | $524.71 | 2019-2023 | Augment Injectable |
| Zimmer Biomet Holdings, INC. | $228.03 | 2020-2022 | |
| Organogenesis INC. | $226.51 | 2022-2024 | |
| Musculoskeletal Transplant Foundation INC. | $134.68 | 2021-2022 | |
| Bioventus LLC | $123.75 | 2019-2023 | Sonicone Clinic |
| Seapearl East, INC | $123.51 | 2024 | |
| Polarityte, INC. | $95.81 | 2020 | |
| Carbofix Orthopedics INC | $77.04 | 2023 | |
| Paratek Pharmaceuticals, INC. | $55.91 | 2022 | |
| Treace Medical Concepts, INC. | $49.32 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $46.07 | 2020-2021 | |
| Horizon Therapeutics Plc | $43.36 | 2019-2021 | |
| Next Science LLC | $30.70 | 2023 | Blastx, Xperience, Surgx |
| Royal Biologics, INC. | $26.75 | 2019 | |
| Misonix INC | $26.07 | 2019 | |
| Zimvie INC. | $16.97 | 2022 | |
| Melinta Therapeutics, LLC | $14.38 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Tamagnini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.